Showing results (491-500 of 529) with videos related to

Sort By:
Pageof 53
Blood|March 9, 2000
Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridizationN Zojer, R Königsberg, J Ackermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3)M Gershanovich, H A Chaudri, D Campos, et al.
Science Advances|July 29, 2026
A comprehensive map of missense trafficking variants in rhodopsin and their response to pharmacologic correctionKannan V Manian, Connor H Ludwig, Yan Zhao, et al.
Voprosy Onkologii|October 26, 1999
[Letrozole (Femara), a new aromatase inhibitor for advanced breast cancer]M Gershanovich, Kh Chaudri, D Campos, et al.
American Journal of Hypertension|November 1, 1993
Genetic basis of familial dyslipidemia and hypertension: 15-year results from UtahR R Williams, S C Hunt, P N Hopkins, et al.
Neuron|August 20, 2019
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived NeuronsRuilin Tian, Mariam A Gachechiladze, Connor H Ludwig, et al.
BMC Medical Genomics|July 9, 2020
Mitochondrial GWAS and association of nuclear - mitochondrial epistasis with BMI in T1DM patientsAgnieszka H Ludwig-Słomczyńska, Michał T Seweryn, Przemysław Kapusta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Predictive role of interphase cytogenetics for survival of patients with multiple myelomaR Königsberg, N Zojer, J Ackermann, et al.
Journal of Diabetes Research|November 4, 2016
Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes MellitusSandra Mrozinska, Piotr Radkowski, Tomasz Gosiewski, et al.
Leukemia|April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomesP Hari, M-V Mateos, R Abonour, et al.
Pageof 53